查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1862862

多体学市场：按技术、体学、产品类型、应用和最终用户划分 - 全球预测 2025-2032

Multiomics Market by Technology, Omics, Product Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，多体学市场将成长至 3,347.5 亿美元，复合年增长率为 16.76%。

关键市场统计数据
基准年 2024 968.6亿美元
预计年份：2025年 1129.9亿美元
预测年份 2032 3347.5亿美元
复合年增长率 (%) 16.76%

策略性地将多组体学定位为一个综合领域，该领域结合了技术进步、数据管治和转化重点，以指导投资。

多组体学正在重塑机构提出和解决生物学挑战的方式。本文将该领域定位在技术、资料科学和转换应用目标的交会点。过去十年，研究人员已从孤立的检测方法转向整合来自基因组学、转录组学、蛋白质组学、代谢体学、脂质组学和表观基因的多层数据的策略。这揭示了单体学方法常常忽略的机制性见解。因此，实验设计现在同样重视样本完整性、统一的元资料和分析的可重复性，从而支持跨体学的可比较性。

随着多组体学应用从发现生物学扩展到临床诊断、药物研发和个人化医疗，相关人员不得不协调不同的监管要求、资料管治框架和检验标准。这种发展趋势凸显了标准化通讯协定和可互通资料格式的重要性，同时也推动了对能够将异质资料集转化为具有临床意义的特征的分析平台的需求。此外，定序化学、质谱灵敏度和计算工具的进步正在降低技术壁垒，并促进湿实验室研究人员、生物资讯学家和临床医生之间的跨学科合作。

综上所述，这些趋势清楚地表明，多组体学既是科学发展的驱动力，也是策略优势。那些能够优化组织流程、投资可重复工作流程并培养数据驱动文化的机构，将更有利于充分利用整合分子谱分析的转换价值。本执行摘要的其余部分说明深入探讨影响多组学应用和竞争差异化的变革性转变、政策影响、市场区隔洞察以及区域性因素。

融合技术的出现、监管法规的演变以及对检验的转化工作流程的需求，正在推动多组体学应用发生重大变革。

多体学领域正经历着变革性的转变，这主要得益于技术的整合进步、临床需求的演变以及新兴资料科学能力的涌现。定序通量和准确性的提高、质谱平台的增强以及自动化样本製备流程的改进，正在降低技术门槛，并拓展可行的研究设计范围。同时，机器学习和网路生物学领域的演算法创新释放新的解读层面，使研究人员能够从复杂的多维资料集中提取基于机制的假设。

同时，监管和伦理方面的考量正在重塑组织机构的资料管理方式。对资料来源可追溯性、审核和跨机构资料共用的日益重视，正在加速对安全平台和联合分析模型的投资，这些平台和模型能够在保护病患隐私的同时，支持大规模的综合研究。临床上对可操作生物标记的需求，以及对分析有效性和临床效用日益增长的期望，正迫使开发人员优先考虑可重复且透明的性能指标。

在营运方面，目前正明显转向端到端解决方案，这些方案提供检验的工作流程，整合耗材、设备和服务。这一趋势有助于加快转换速度，并减轻最终用户的整合负担。这些变化正在创造一个环境，​​在这个环境中，策略伙伴关係、平台间的互通性以及可证实的临床影响将决定长期的成功。

分析关税带来的供应链压力如何迫使体学学价值链采取在地化、供应商多元化和弹性筹资策略。

2025年美国关税政策对多组体学生态系统内的供应链韧性、筹资策略和成本结构提出了新的考量。实验室设备、试剂和进口组件的关税可能会增加到岸成本，促使製造商和采购商评估其他采购方案、实现关键生产过程的本地化或重新谈判供应商合约。为此，许多机构正在重新评估其平台投资的整体拥有成本，并优先考虑供应链透明且製造地分布广泛的供应商。

这些政策转变也凸显了区域伙伴关係和分散式製造模式的战略价值。能够扩大本地组装、耗材生产和试剂填充能力的企业将在关税压力下获得竞争优势，而拥有灵活且区域分布的实验室的服务供应商可以通过将样品处理重新分配到贸易条件有利、进口关税较低的设施来降低风险。

在采购方面，实验室和商业检测实验室越来越多地采用多年期合约、避险策略和库存管理技术来应对短期价格波动。同时，对上游采购计画的透明度需求日益增长，供应商审核和涵盖关税相关风险的合约条款也变得越来越重要。因此，政策环境正推动产业建构更具韧性、更透明、地理分布更广的供应链，以在管理营运风险的同时，维持科学研究工作的连续性。

全面的細項分析揭示了技术选择、体学方法、产品类型、应用领域和最终用户需求如何决定采用路径和价值创造。

关键的市场区隔分析揭示了技术选择、科学研究重点和终端用户需求之间的交集，从而塑造了技术应用路径和价值提案。按技术划分，市场涵盖质谱、微阵列、qPCR 和定序，其中定序又细分为次世代定序(NGS) 和桑格定序。这项技术组合决定了研究人员可应用的下游分析的通量、灵敏度和性质。体学领域涵盖表观表观基因、基因组学、脂质组学、代谢体学、蛋白质组学和转录组学。每个体学层面都提供独特的生物学背景，同时也带来了与样品製备、动态范围和数据整合相关的分析挑战。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 推出精准肿瘤学研究的AI驱动多体学资料整合平台
  • 空间转录组学和蛋白​​质组学融合技术的出现，为绘製肿瘤微环境图谱提供了可能。
  • 整合代谢体学和表观基因以识别神经退化性疾病中的新型生物标记
  • 对云端基础的多组体学分析工作流程的需求日益增长，以简化大规模资料处理。
  • 开发用于快速照护现场的携带式多体学检体製备试剂套件
  • 扩大液态生物检体体学学检测规模，用于早期癌症检测和微量残存疾病监测
  • 製药公司与多体学技术提供者在药物标靶发现方面的合作日益增多。
  • 利用体学和体学的整合进行个人化营养管理和代谢疾病管理

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依科技分類的多组体学市场

  • 质谱分析
  • 微阵列
  • qPCR
  • 定序
    • 次世代定序
    • 桑格定序

第九章：多体学体学市场

  • 表观基因
  • 基因组学
  • 脂质体学
  • 代谢体学
  • 蛋白质体学
  • 转录组学

第十章 多组体学市场（依产品类型划分）

  • 消耗品
  • 装置
  • 软体和服务
    • 服务
      • 数据分析
      • 样品製备
    • 软体

第十一章 多组体学市场按应用领域划分

  • 农业和食品检验
  • 生物标记发现
  • 临床诊断
  • 药物发现与开发
  • 个人化医疗

第十二章 依最终用户分類的多组体学市场

  • 学术研究机构
  • CRO（受託研究机构）
  • 医院和诊断实验室
  • 製药和生物技术公司

第十三章：各地区的多组体学市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 多组体学市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国多组体学市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc.
    • Danaher Corporation
    • Roche Holding AG
    • Agilent Technologies, Inc.
    • QIAGEN NV
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer, Inc.
    • Bruker Corporation
    • Waters Corporation
Product Code: MRR-CF699CF41428

The Multiomics Market is projected to grow by USD 334.75 billion at a CAGR of 16.76% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 96.86 billion
Estimated Year [2025] USD 112.99 billion
Forecast Year [2032] USD 334.75 billion
CAGR (%) 16.76%

A strategic introduction framing multiomics as an integrative discipline that fuses technological advances, data governance, and translational priorities to guide investment

Multiomics is reshaping how organizations ask and answer biological questions, and this introduction situates the field at the intersection of technology, data science, and translational ambition. Over the past decade, practitioners have moved beyond siloed assays to integrated strategies that layer genomics, transcriptomics, proteomics, metabolomics, lipidomics, and epigenomics data to reveal mechanistic insights that single-omic approaches often miss. Consequently, experimental design now places equal emphasis on sample integrity, harmonized metadata, and analytical reproducibility to support cross-omic comparability.

As multiomics applications expand from discovery biology into clinical diagnostics, drug development, and personalized medicine, stakeholders must reconcile differing regulatory expectations, data governance frameworks, and validation requirements. This evolution elevates the importance of standardized protocols and interoperable data formats, while simultaneously driving demand for analytics platforms that translate heterogenous datasets into clinically meaningful signatures. Moreover, advances in sequencing chemistry, mass spectrometry sensitivity, and computational tools have reduced technical barriers, encouraging cross-disciplinary collaboration among wet-lab scientists, bioinformaticians, and clinicians.

Taken together, these dynamics position multiomics as both a scientific enabler and a strategic lever. Institutions that align organizational processes, invest in reproducible workflows, and foster data-driven cultures are best placed to capture the translational value of integrated molecular profiling. The remainder of this executive summary unpacks the transformative shifts, policy impacts, segmentation insights, and regional considerations that will shape adoption and competitive differentiation.

Key transformative shifts reshaping multiomics adoption driven by convergent technologies, regulatory evolution, and demand for validated translational workflows

The landscape of multiomics is undergoing transformative shifts driven by converging technological advances, evolving clinical priorities, and emergent data science capabilities. Improvements in sequencing throughput and accuracy, enhanced mass spectrometry platforms, and automated sample preparation workflows are lowering technical friction and expanding the range of feasible study designs. Simultaneously, algorithmic innovations in machine learning and network biology are unlocking new interpretive layers, enabling researchers to extract mechanistic hypotheses from complex, multi-dimensional datasets.

At the same time, regulatory and ethical considerations are reshaping how organizations approach data stewardship. Greater emphasis on provenance, auditability, and cross-institutional data sharing is accelerating investments in secure platforms and federated analysis models that preserve patient privacy while enabling large-scale integrative studies. Clinical demand for actionable biomarkers, coupled with heightened expectations for analytical validation and clinical utility, is pushing developers to prioritize reproducibility and transparent performance metrics.

Operationally, there is a clear move toward end-to-end solutions that combine consumables, instruments, and services into validated workflows. This trend supports faster translational timelines and reduces the integration burden for end users. Taken together, these shifts create an environment where strategic partnerships, platform interoperability, and demonstrable clinical impact determine long-term success.

Analyzing how tariff-driven supply chain pressures compel localization, supplier diversification, and resilient procurement strategies across the multiomics value chain

The 2025 tariff environment in the United States has introduced tangible considerations for supply chain resilience, procurement strategy, and cost structure within the multiomics ecosystem. Tariffs on laboratory instruments, reagents, or imported components can increase landed costs, prompting manufacturers and buyers to evaluate sourcing alternatives, localize critical production steps, or renegotiate supplier agreements. In response, many organizations are reassessing total cost of ownership for platform investments and prioritizing vendors that demonstrate transparent supply chains and diversified manufacturing footprints.

These policy shifts also amplify the strategic value of regional partnerships and distributed manufacturing models. Firms that can scale localized assembly, consumable production, or reagent fill-and-finish capacities gain a competitive advantage under tariff pressures. Meanwhile, service providers with flexible, regionally distributed laboratories can mitigate exposure by reallocating sample processing to facilities with preferential trade terms or lower import duties.

From a procurement perspective, research institutions and commercial labs are increasingly adopting multi-year contracts, hedging strategies, and inventory management practices to absorb short-term price volatility. At the same time, the need for clear visibility into upstream component sourcing has elevated supplier audits and contractual clauses that address tariff-related liabilities. Ultimately, the policy environment is pushing the sector toward more resilient, transparent, and geographically diversified supply chains that preserve scientific continuity while controlling operational risk.

Comprehensive segmentation insights revealing how technology choices, omic modalities, product types, applications, and end-user needs determine adoption pathways and value creation

Key segmentation insights reveal where technological choices, scientific priorities, and end-user needs intersect to shape adoption pathways and value propositions. Based on Technology, the market encompasses Mass Spectrometry, Microarrays, qPCR, and Sequencing, with Sequencing further segmented into Next Generation Sequencing and Sanger Sequencing; this technological palette determines throughput, sensitivity, and the nature of downstream analytics that researchers can apply. Based on Omics, the field spans Epigenomics, Genomics, Lipidomics, Metabolomics, Proteomics, and Transcriptomics; each omic layer contributes distinct biological context and poses unique analytical challenges related to sample prep, dynamic range, and data integration.

Based on Product Type, offerings include Consumables, Instruments, and Software and Services, with Software and Services further differentiated into Services and Software, and Services subdivided into Data Analysis and Sample Preparation; such product taxonomy underscores the growing importance of bundled solutions that combine hardware with analytical and preparatory services. Based on Application, primary use cases encompass Agriculture and Food Testing, Biomarker Discovery, Clinical Diagnostics, Drug Discovery and Development, and Personalized Medicine; these applications drive differing requirements for regulatory compliance, throughput, and interpretive frameworks. Based on End User, the ecosystem serves Academic and Research Institutes, Contract Research Organizations, Hospitals and Diagnostic Laboratories, and Pharmaceutical and Biotechnology Companies; each end-user segment prioritizes distinct value drivers, from exploratory flexibility to validated, clinically compliant workflows.

Interpreting these segmentations together highlights where investments will matter most: platforms that enable high-quality sample processing, interoperable data pipelines that support multi-omic integration, and services that reduce technical barriers for non-specialist end users. In short, success hinges on aligning technological capabilities with application-specific needs and end-user operational realities.

Actionable regional insights describing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence adoption, regulation, and partnership strategies in multiomics

Regional dynamics exert a powerful influence on technology deployment, regulatory alignment, and partnership strategies across the multiomics landscape. In the Americas, research intensity, venture funding, and a robust network of biotech clusters drive rapid adoption of advanced sequencing and mass spectrometry platforms, while a complex patchwork of reimbursement and regulatory frameworks requires targeted validation strategies. Meanwhile, academic-industry collaborations and contract research organizations in the region foster translational pipelines that accelerate proof-of-concept studies and early clinical adoption.

Across Europe, Middle East & Africa, regulatory harmonization efforts, strong public research infrastructures, and growing commercial investment support methodical integration of multiomics into healthcare and agricultural applications. Stakeholders in these markets often prioritize interoperability, data protection, and harmonized performance standards, creating demand for validated workflows and compliant analytics. In Asia-Pacific, rapid infrastructure build-out, manufacturing scale, and government-led science initiatives are expanding local production capacities and driving aggressive adoption of sequencing technologies and automated sample handling systems. The region's diverse regulatory environments and large patient populations also create opportunities for large-scale cohort studies and localized biomarker discovery.

Collectively, these regional characteristics underscore the need for geographically nuanced strategies. Organizations must tailor commercialization, regulatory, and partnership approaches to regional priorities, balancing global platform standardization with local operational flexibility.

Key company insights highlighting how platform integration, validation capabilities, and service differentiation determine competitive advantage across multiomics players

Competitive dynamics in multiomics center on the ability to deliver reliable, validated end-to-end solutions that combine high-performance instruments, reproducible consumables, and scalable analytics. Key companies distinguish themselves through investments in platform interoperability, demonstrated clinical or agricultural utility, and partnerships that extend their value proposition into downstream applications. Strategic M&A and partnership activity continues to align specialized capabilities-such as niche sample preparation chemistry or advanced informatics-with broader platform providers seeking comprehensive offerings.

Market differentiation also arises from service excellence; organizations that provide robust validation support, regulatory documentation, and training resources secure deeper customer relationships. Similarly, firms that offer modular software with open APIs facilitate integration into existing laboratory information management systems and analysis pipelines, lowering barriers for enterprise adoption. Investors and strategic partners increasingly prize companies that demonstrate end-user-focused commercialization strategies, geographic manufacturing resilience, and transparent data governance practices. Ultimately, market leaders combine technical credibility with commercial agility, enabling them to scale adoption across academic, clinical, and industrial customers.

Actionable recommendations for industry leaders to enhance platform interoperability, supply chain resilience, regulatory support, and service-led commercialization strategies

Industry leaders can accelerate value capture by aligning strategic actions with technological and regulatory realities while prioritizing resilience and customer-centricity. First, investing in interoperable platforms and open data standards reduces integration friction and increases the appeal of solutions across end users with heterogeneous infrastructure. Next, expanding localized manufacturing or establishing regional partnerships mitigates tariff and supply chain risks, while offering faster turnaround times for critical consumables and reagents.

Additionally, integrating comprehensive validation packages and regulatory support into product offerings lowers adoption barriers in clinical and diagnostic contexts. Leaders should also develop tiered service models that include sample preparation, data analysis, and clinical interpretation to address the needs of both high-throughput research centers and diagnostic laboratories. To cultivate long-term trust, companies must implement transparent data governance frameworks and robust provenance tracking to satisfy institutional and regulatory auditors. Finally, strengthening cross-disciplinary talent pipelines-combining wet-lab expertise, computational biology, and regulatory affairs-ensures organizations can translate multiomic data into actionable biological and clinical insights. These recommendations form a pragmatic blueprint for organizations seeking to scale responsibly and sustainably.

A rigorous mixed-methods research methodology combining expert primary interviews with systematic secondary evidence synthesis to ensure analytic validity and relevance

The research methodology blends primary and secondary evidence to ensure analytical rigor, reproducibility, and relevance. Primary research included structured interviews with domain experts, laboratory directors, and service providers to capture operational realities, validation practices, and procurement drivers. These qualitative inputs were triangulated with technical literature, peer-reviewed studies, and vendor documentation to verify claims about platform capabilities, assay limitations, and analytical workflows.

Secondary research encompassed a systematic review of scientific publications, regulatory guidance documents, and white papers that illuminate technological trends and application-specific requirements. Data collection prioritized sources that detail assay performance characteristics, sample handling best practices, and interoperability standards. Findings were synthesized using thematic analysis and cross-validation steps to surface consistent patterns and areas of divergence. Throughout the process, attention to provenance, methodological transparency, and source credibility underpinned analytical choices, ensuring that conclusions rest on verifiable evidence and reflect current industry practices.

A conclusive synthesis emphasizing the need for validated workflows, interoperable platforms, and resilient commercialization strategies to realize multiomics impact

In conclusion, multiomics represents a strategic inflection point in life sciences where integrated molecular profiling, advanced instrumentation, and sophisticated analytics converge to enable deeper biological insight and translational impact. The field's maturation depends on aligning technological innovation with robust data governance, standardized workflows, and commercially viable service models that lower barriers to adoption. Policy shifts and trade dynamics have highlighted the importance of supply chain resilience and regional agility, making localization and partnership strategies central to long-term operational continuity.

Looking ahead, organizations that prioritize platform interoperability, end-to-end validation, and customer-focused service offerings will be best positioned to translate multiomic data into clinical and commercial outcomes. Cross-sector collaboration among instrument vendors, software developers, service providers, and end users will accelerate the development of validated workflows and reproducible evidence, thereby expanding the range of practical applications. Ultimately, the pathway to impact lies in coupling scientific rigor with pragmatic commercialization and governance frameworks that foster trust, scalability, and measurable benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-driven multiomics data integration platforms for precision oncology research
  • 5.2. Emergence of spatial transcriptomics combined with proteomics to map tumor microenvironments
  • 5.3. Integration of metabolomics and epigenomics analyses to identify novel biomarkers in neurodegenerative diseases
  • 5.4. Rising demand for cloud-based multiomics analysis workflows to streamline large dataset processing
  • 5.5. Development of portable multiomics sample preparation kits for rapid point-of-care diagnostics
  • 5.6. Expansion of liquid biopsy multiomics assays for early cancer detection and minimal residual disease monitoring
  • 5.7. Increasing partnerships between pharma and multiomics technology providers for drug target discovery
  • 5.8. Utilization of lipidomics and glycomics integration in personalized nutrition and metabolic disorder management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Multiomics Market, by Technology

  • 8.1. Mass Spectrometry
  • 8.2. Microarrays
  • 8.3. qPCR
  • 8.4. Sequencing
    • 8.4.1. Next Generation Sequencing
    • 8.4.2. Sanger Sequencing

9. Multiomics Market, by Omics

  • 9.1. Epigenomics
  • 9.2. Genomics
  • 9.3. Lipidomics
  • 9.4. Metabolomics
  • 9.5. Proteomics
  • 9.6. Transcriptomics

10. Multiomics Market, by Product Type

  • 10.1. Consumables
  • 10.2. Instruments
  • 10.3. Software and Services
    • 10.3.1. Services
      • 10.3.1.1. Data Analysis
      • 10.3.1.2. Sample Preparation
    • 10.3.2. Software

11. Multiomics Market, by Application

  • 11.1. Agriculture and Food Testing
  • 11.2. Biomarker Discovery
  • 11.3. Clinical Diagnostics
  • 11.4. Drug Discovery and Development
  • 11.5. Personalized Medicine

12. Multiomics Market, by End User

  • 12.1. Academic and Research Institutes
  • 12.2. Contract Research Organizations
  • 12.3. Hospitals and Diagnostic Laboratories
  • 12.4. Pharmaceutical and Biotechnology Companies

13. Multiomics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Multiomics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Multiomics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Illumina, Inc.
    • 16.3.3. Danaher Corporation
    • 16.3.4. Roche Holding AG
    • 16.3.5. Agilent Technologies, Inc.
    • 16.3.6. QIAGEN N.V.
    • 16.3.7. Bio-Rad Laboratories, Inc.
    • 16.3.8. PerkinElmer, Inc.
    • 16.3.9. Bruker Corporation
    • 16.3.10. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MULTIOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MULTIOMICS MARKET SIZE, BY OMICS, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MULTIOMICS MARKET SIZE, BY OMICS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MULTIOMICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MULTIOMICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MULTIOMICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MULTIOMICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MULTIOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MULTIOMICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MULTIOMICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS MULTIOMICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS MULTIOMICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. AFRICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 310. AFRICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. GLOBAL MULTIOMICS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 336. GLOBAL MULTIOMICS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 337. ASEAN MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. ASEAN MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. ASEAN MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 340. ASEAN MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 341. ASEAN MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 342. ASEAN MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 343. ASEAN MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 344. ASEAN MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 345. ASEAN MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. ASEAN MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. ASEAN MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 348. ASEAN MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 349. ASEAN MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 350. ASEAN MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 351. ASEAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 352. ASEAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 353. ASEAN MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 354. ASEAN MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 355. GCC MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 356. GCC MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 357. GCC MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 201